转移相关蛋白2在头颈部恶性肿瘤中的作用
作者:
基金项目:

邵阳市科技计划项目(2021GZ035)。


Effect of MTA2 in head and neck malignant tumors
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    转移相关蛋白2(MTA2)是近年来被发现的与肿瘤侵袭进展、转移相关的转录调控家族成员,在肿瘤的增殖、侵袭以及远处转移中起着非常重要的作用。其在多种头颈部恶性肿瘤如鼻咽癌、口腔癌、喉癌、食管癌、甲状腺癌中呈高表达,并且MTA2的高表达与这些恶性肿瘤的不良预后相关。MTA2与头颈部恶性肿瘤的侵袭、进展及预后的关系研究成为了头颈肿瘤研究中的新热点。本文对MTA2的结构与功能、其在不同头颈肿瘤中的表达以及意义、其可能的调节机制以及其研究展望作一个小结,希望对MTA2的后续研究以及头颈肿瘤的综合诊治提供帮助。

    Abstract:

    Metastasis associated protein 2 (MTA2) is a member of the transcriptional regulation family that has been discovered recently and is associated with tumor invasion, progression and metastasis, which plays a very important role in tumor proliferation, invasion and distant metastasis. MTA2 is highly expressed in a variety of head and neck malignancies, such as nasopharyngeal carcinoma, oral carcinoma, larynx cancer, esophageal cancer, thyroid cancer, and other malignancies. The high expression of MTA2 is associated with poor prognosis of these malignancies. The relationship between MTA2 and the invasion, progression and prognosis of head and neck malignant tumors has become a new hotspot in the research of head and neck tumors. This paper makes a summary of the structure and function of MTA2, its expression and significance in different head and neck tumors, its possible regulatory mechanism and its research prospect. We hope to provide some help for the follow-up study of MTA2 and the comprehensive diagnosis and treatment of head and neck tumors.

    网友评论
    网友评论
    分享到微博
    发 布
    参考文献
    [1] 陶磊,吴春萍,徐成志,等.头颈肿瘤外科临床治疗新技术与应用[J].中国耳鼻咽喉颅底外科杂志,2023,29(2):1-7.
    [2] 金哲,张璐,张斌,等.头颈部肿瘤影像组学研究进展[J].中华放射学杂志, 2020, 54(2):5.
    [3] 贾敏鑫,李东霞.皮肤恶性肿瘤转移机制的研究[J].医学信息,2021,34(8):36-40.
    [4] Hsu WH,Chiou HL,Lin CL,et al.Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways[J].J Cancer,2019,26:6716-6725.
    [5] Si W,Liu X,Wei R,et al.MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity[J].Cell Death Dis,2019,10(3):206.
    [6] Zhou Z,Yang P,Zhang B,et al. Long noncoding RNA TTC39A-AS1 promotes breast cancer tumorigenicity by sponging microRNA-483-3p and thereby upregulating MTA2[J]. Pharmacology, 2021,106(11-12):573-587.
    [7] El-Nikhely N,Karger A,Sarode P,et al.Metastasis-associated protein 2 represses NF-κB to Reduce lung tumor growth and inflammation[J].Cancer Res,2020,19:4199-4211.
    [8] 甄娟,刘玉东,宋春红,等.卵巢上皮性癌中MTA2的表达及预后价值[J].临床与实验病理学杂志, 2019,35(3):304-308.
    [9] Kumar R, Wang RA.Structure, expression and functions of MTA genes[J].Gene, 2016, 582(2):112-121.
    [10] 姜合理.酵母复制原点识别蛋白Orc1的BAH结构域在转录沉默中的结构与功能研究[D].北京:中国科学院大学,2020.
    [11] 杨阳.BCL11A识别γ-珠蛋白基因启动子的结构基础以及BAF180与核小体互作的结构与功能研究[D]. 北京:中国科学技术大学,2019.
    [12] Ding Z,Gillespie LL,Paterno GD.Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain[J].Mol Cell Biol,2003,23(1):250-258.
    [13] Wang L,Charroux B,Kerridge S,et al.Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates[J].EMBO Rep,2008,9(6):555-562.
    [14] Wu M, Ye X, Deng X,et al.Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma[J].Onco Targets Ther, 2016, 9:1647-1656.
    [15] Zhang BJ,Lan GP,Si JY,et al.Correlation of metastasis-associated protein expression with prognosis and chemotherapy in nasopharyngeal carcinoma[J].Int J Clin Exp Pathol,2018,11(5):2537-2549.
    [16] Tseng TY,Chiou HL,Lin CW,et al.Repression of metastasis-associated protein 2 for inhibiting metastasis of human oral cancer cells by promoting the p-cofilin-1/ LC3-II expression[J].J Oral Pathol Med,2019,48(100):959-966.
    [17] Luan S,Fu P,Wang X,et al.Circular RNA circ-NCOR2 accelerates papillary thyroid cancer progression by sponging miR-516a-5p to upregulate metastasis-associated protein 2 expression[J].J Int Med Res,2020, 48(9):1-12.
    [18] Dai SL,Wei SS,Zhang C,et al.MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop[J].Cancer Sci, 2021,112(3):1060-1074.
    [19] Wei S,Sun S,Zhou X,et al.SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer[J].Carcinogenesis,2021,42(2):315-326.
    [20] 刘玉东,甄娟,韩晓丽,等. 转移相关蛋白2、锌指转录蛋白与基质金属蛋白酶9在喉鳞状细胞癌中的表达及临床意义[J]. 中国耳鼻咽喉头颈外科,2020,27(9):507-511.
    [21] 马鹏,冯俊,杜经纬.转移相关基因2对喉癌细胞系Hep-2的增殖、迁移和侵袭的影响[J].川北医学院学报, 2017, 32(2):172-174.
    [22] 刘芳.GM12878细胞系和K562细胞系组蛋白修饰对基因表达的影响[D]. 呼和浩特:内蒙古大学, 2020.
    [23] 闫昊一,张宏权.组蛋白酰基化修饰作用及其相关技术进展[J].中国科学:生命科学,2023,53(11):1613-1625.
    [24] 杨涛,马小倩,张全,等.组蛋白修饰在水稻中的研究进展[J].中国农业科技导报, 2022,24(4):11-20.
    [25] Lu X,Chu CS,Fang T,et al.MTA2/NuRD regulates B cell development and cooperates with OCA-B in controlling the Pre-B to immature B cell transition[J].Cell Reports,2019,28(2):472-485.
    [26] Covington KR,Brusco L,Barone I,et al.Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer[J].Breast Cancer Res Treat,2013,141(3):375-384.
    [27] Amit S, Anupam B, Abhay P.Targeting histone deacetylases with natural and synthetic agents: An emerging anticancer strategy[J].Nutrients, 2018, 10(6):731.
    [28] 方晨,王勇,李勇.组蛋白去乙酰化酶抑制剂联合免疫检查点抑制剂治疗肿瘤的研究进展[J].中国肺癌杂志,2021,4(3),204-211.
    引证文献
引用本文

张屹,杨枝芳.转移相关蛋白2在头颈部恶性肿瘤中的作用[J].中国耳鼻咽喉颅底外科杂志,2024,30(3):52-55

复制
分享
文章指标
  • 点击次数:46
  • 下载次数: 129
历史
  • 收稿日期:2023-11-26
  • 在线发布日期: 2024-07-03
温馨提示

本刊唯一投稿网址:www.xyosbs.com
唯一办公邮箱:xyent@126.com
编辑部联系电话:0731-84327210,84327469
本刊从未委托任何单位、个人及其他网站代理征稿及办理其他业务联系,谨防上当受骗!

关闭